Benign antibiotic creating ‘almost untreatable superbug’ via cross-resistance
Prophylactic use of the antibiotic rifaximin is fuelling a dangerous multidrug-resistant pathogen, Australian scientists say. The team says rifaximin causes cross-resistance to the unrelated antibiotic…